KPX Lifescience.Co.Ltd (114450) — Capital Reinvestment Ratio
Latest as of September 2025:
0.08x
KPX Lifescience.Co.Ltd (114450) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.33 Billion) in capital expenditures (₩275.98 Million). See cash generation quality of KPX Lifescience.Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.33 Billion
KRW
Capital Expenditures
₩275.98 Million
KRW
Data as of
Sep 2025
Most recent filing
KPX Lifescience.Co.Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks KPX Lifescience.Co.Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for KPX Lifescience.Co.Ltd from 2014 to 2024. For live market cap and broader valuation context, see market cap of KPX Lifescience.Co.Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.88x | ₩525.49 Million | ₩462.71 Million | ▼ -31.4% |
| 2023 | 1.28x | ₩370.02 Million | ₩475.02 Million | ▼ -77.2% |
| 2021 | 5.63x | ₩611.38 Million | ₩3.44 Billion | ▲ +301.7% |
| 2020 | 1.40x | ₩1.90 Billion | ₩2.67 Billion | ▲ +65.2% |
| 2019 | 0.85x | ₩4.24 Billion | ₩3.60 Billion | ▼ -39.0% |
| 2018 | 1.39x | ₩5.38 Billion | ₩7.49 Billion | ▲ +83.6% |
| 2017 | 0.76x | ₩5.68 Billion | ₩4.31 Billion | ▲ +234.5% |
| 2016 | 0.23x | ₩7.07 Billion | ₩1.60 Billion | ▲ +141.7% |
| 2015 | 0.09x | ₩5.62 Billion | ₩526.82 Million | ▼ -54.3% |
| 2014 | 0.21x | ₩4.09 Billion | ₩838.78 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow